Skip to content

Tesamorelin

PeptidespeptideEarly stage

Availability Off-label prescription

What it is

Tesamorelin is a stabilized analog of growth-hormone-releasing hormone and the only compound on the growth hormone peptide menu that is an approved American drug today. It is sold as Egrifta, and its approval is narrow: reducing excess abdominal fat in adults with HIV who have lipodystrophy. Nothing else.

Why people take it

Off-label interest follows the one thing tesamorelin has been shown to do, which is shrink visceral fat, the deep abdominal fat most tied to metabolic risk. That is a more concrete target than most of this lane offers, and it draws people who want body composition changed rather than a vague anti-aging signal.

How it's delivered

The approved product is a daily subcutaneous injection. Some longevity clinics advertise compounded tesamorelin, but these products are unapproved; tesamorelin's biologic status excludes it from 503A and 503B compounding exemptions. Visceral fat is measured by imaging, so honest tracking means a scan rather than a scale.

Where the evidence stands

Within its indication, solid. Registration trials supported the visceral fat claim, and a 12-month randomized trial in people with HIV and fatty liver found tesamorelin reduced liver fat by about 37 percent relative to baseline against placebo, with a third of participants dropping below the threshold for fatty liver. Outside that population the evidence thins fast. Tesamorelin has been studied for cognition and body composition in older adults without HIV, but no trial has established a longevity benefit, the label carries warnings around glucose intolerance and fluid retention, and gains reverse when treatment stops. Anti-doping rules prohibit it.

Estimated cost

  • About $11,030 per 28-day kit for the branded product at the US cash price
  • Source: Drugs.com Egrifta WR price guide, checked 2 Nov 2026
  • Insurance covers the approved HIV indication, not longevity use
  • Daily injection, so cost is continuous rather than per course

Who offers it

We don't list clinics that advertise compounded tesamorelin: those products are unapproved, and tesamorelin's biologic status excludes it from 503A and 503B compounding exemptions. The approved product is prescribed through a physician and dispensed by a pharmacy.

Go deeper

The compound page, Tesamorelin in the Peptide Explorer, is the depth layer. The lane guide, Peptides for Growth Hormone Support, covers the axis and how an approved indication differs from a marketing claim.

Longevity.io is for educational purposes only and is not medical advice. An approval for one condition is not evidence for another. Confirm eligibility, product source, and pricing directly with any provider.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint